Literature DB >> 9014825

Peptides isolated from random peptide libraries on phage elicit a neutralizing anti-HIV-1 response: analysis of immunological mimicry.

K Lundin1, A Samuelsson, M Jansson, J Hinkula, B Wahren, H Wigzell, M A Persson.   

Abstract

Peptides binding to a murine, human immunodeficiency virus type 1 (HIV-1) neutralizing monoclonal antibody (F58/H3) were isolated from two random peptide libraries expressed on the surface of phage. The antibody was originally elicited by immunization with HIV-1 envelope protein gp120LAI, and has previously been shown to interact with the -I-GPGRA- motif of the V3 loop. The peptide libraries consisted of nine or 15 random amino acid residues flanked by two cysteines, and fused to the amino terminal end of the cpIII protein on the filamentous phage. Selection of specific peptides was carried out in three rounds, with decreasing antibody concentration. An expected peptide motif -GPGRA-, a similar segment, -GPAR-, and two unrelated motifs -FRLLG- and -WRM/ALG- were selected. Binding of antibody was tested both to synthetic peptides in solution, and the corresponding peptide on phage. The GPXR motifs bound in both formats, while the FRLLG bound antibody only when present on the phage The reactivity of peptides on phage was highly dependent on an intact disulphide bond between the cysteines flanking the peptide. The molecular mimicry of the found motifs was tested by immunizing mice and rabbits with conjugated synthetic peptides or peptide on phage. In mice, peptide-specific antisera were raised, but no reactivity to the whole protein (gp120) was detected. In rabbits, however, this was accomplished with the -GPGRA- containing peptide when present on phage. In addition, this antisera precipitated virus particles, and neutralized HIV-1SF2 virus in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9014825      PMCID: PMC1456581          DOI: 10.1046/j.1365-2567.1996.d01-772.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.

Authors:  L Akerblom; J Hinkula; P A Broliden; B Mäkitalo; T Fridberger; J Rosen; M Villacres-Eriksson; B Morein; B Wahren
Journal:  AIDS       Date:  1990-10       Impact factor: 4.177

2.  Assembly of combinatorial antibody libraries on phage surfaces: the gene III site.

Authors:  C F Barbas; A S Kang; R A Lerner; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces.

Authors:  A S Kang; C F Barbas; K D Janda; S J Benkovic; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

4.  Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP.

Authors:  S Blond-Elguindi; S E Cwirla; W J Dower; R J Lipshutz; S R Sprang; J F Sambrook; M J Gething
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

5.  Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120.

Authors:  K S Steimer; C J Scandella; P V Skiles; N L Haigwood
Journal:  Science       Date:  1991-10-04       Impact factor: 47.728

6.  Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody.

Authors:  D D Ho; J A McKeating; X L Li; T Moudgil; E S Daar; N C Sun; J E Robinson
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

7.  Identification of HIV vaccine candidate peptides by screening random phage epitope libraries.

Authors:  P M Keller; B A Arnold; A R Shaw; R L Tolman; F Van Middlesworth; S Bondy; V K Rusiecki; S Koenig; S Zolla-Pazner; P Conard
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

8.  Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  P A Broliden; A von Gegerfelt; P Clapham; J Rosen; E M Fenyö; B Wahren; K Broliden
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

9.  Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies.

Authors:  P A Broliden; B Mäkitalo; L Akerblom; J Rosen; K Broliden; G Utter; M Jondal; E Norrby; B Wahren
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

10.  Synthetic peptides as the basis for vaccine design.

Authors:  R Arnon
Journal:  Mol Immunol       Date:  1991-03       Impact factor: 4.407

View more
  6 in total

1.  p185, an immunodominant epitope, is an autoantigen mimotope.

Authors:  Sanjeev Kumar; John A Hinks; Joseph Maman; Chelliah T Ravirajan; Laurence H Pearl; David A Isenberg
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

2.  B cell epitopes within VP1 of type O foot-and-mouth disease virus for detection of viral antibodies.

Authors:  Shan-dian Gao; Jun-zheng Du; Hui-yun Chang; Guo-zheng Cong; Jun-Jun Shao; Tong Lin; Shuai Song; Qing-ge Xie
Journal:  Virol Sin       Date:  2010-02-12       Impact factor: 4.327

3.  An artificial cell-cycle inhibitor isolated from a combinatorial library.

Authors:  B A Cohen; P Colas; R Brent
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

4.  Peptide mimotopes selected from a random peptide library for diagnosis of Epstein-Barr virus infection.

Authors:  Joanne L Casey; Andrew M Coley; Graham Street; Kathy Parisi; Peter L Devine; Michael Foley
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

5.  Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition.

Authors:  C Putterman; B Diamond
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

Review 6.  Phage display in the study of infectious diseases.

Authors:  Lisa M Mullen; Sean P Nair; John M Ward; Andrew N Rycroft; Brian Henderson
Journal:  Trends Microbiol       Date:  2006-02-07       Impact factor: 17.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.